Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma

NCT05526989 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Penile Carcinoma

Interventions

DRUG: Dostarlimab
DRUG: Niraparib

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]